Protalix BioTherapeutics (PLX) Misses Q2 EPS by 17c
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $1.15 -2.54%
Financial Fact:
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED:: -0.07
Today's EPS Names:
RBKB, BPRN, OFED, More
Financial Fact:
NET LOSS PER SHARE OF COMMON STOCK - BASIC AND DILUTED:: -0.07
Today's EPS Names:
RBKB, BPRN, OFED, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.25), $0.17 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $6.43 million versus the consensus estimate of $8.3 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oconee Federal Financial (OFED) Tops Q3 EPS by 57c
- Peoples Financial Services Group (PFIS) Misses Q1 EPS by 10c
- Citizens Financial Services, Inc. (CZFS) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
